1. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm. Res.,1995
2. US Department of Health and Human Service, FDA Center for Drug Evaluation and Research (CDER) Draft Guidance: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Dosage Forms Containing Certain Active Moieties/Active Ingredients Based on a Biopharmaceutic Drug Classification System, CDERGUID/2062 DFT.WPD, 6 Janaury 1999.
3. The Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals, 13th ed., Whitehouse, 1996, p. 1528, 2001.
4. Chemistry and analysis of silymarin from Silybum marianum gaertn;Wagner;Arzneim. Forsch.,1974
5. Silymarin: what is in the name … ? An appeal for a change of editorial policy;Šimánek;J. Hepatol.,2000